Lowe v. Shieldmark, Inc.

Court of Appeals for the Federal Circuit·Decided March 4, 2022·No. 21-2164·Unpublished

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit

CLIFFORD A. LOWE, INSITE SOLUTIONS, LLC, Plaintiffs-Appellants

v.

SHIELDMARK, INC., ADVANCED PLASTICS, INC., CROWN EQUIPMENT CORPORATION, Defendants-Appellees

2021-2164

Appeal from the United States District Court for the Northern District of Ohio in No. 1:19-cv-00748-JG, Judge James S. Gwin.

Decided: March 4, 2022

RAY L. WEBER, Renner, Kenner, Greive, Bobak, Taylor & Weber, Akron, OH, argued for plaintiffs-appellants. Also represented by LAURA J. GENTILCORE.

RICHARD BURNS MEGLEY, JR., Lee Sheikh Megley & Haan LLC, Chicago, IL, argued for defendants-appellees. Also represented by DAVID J. SHEIKH; HOWARD WERNOW, Sand, Sebolt & Wernow Co., LPA, Canton, OH.

2 LOWE v. SHIELDMARK, INC.

Before LOURIE, BRYSON, and CUNNINGHAM, Circuit Judges.

LOURIE, Circuit Judge.

Clifford A. Lowe and InSite Solutions, LLC (“Lowe”)

appeal from the decisions of the United States District Court for the Northern District of Ohio (1) granting summary judgment following claim construction that Shield- Mark, Inc. et al. (“ShieldMark”) does not infringe claims 1– 6, 10–16, and 20–21 of U.S. Patent 10,214,664 (“the ’664 patent”), (2) dismissing Lowe’s claim for a declaratory judgment of invalidity and unenforceability of U.S. Patent 10,738,220 (“the ’220 patent”), and (3) denying attorney fees. Lowe v. ShieldMark, Inc., No. 1:19-CV-748, 2021 WL 2530219 (N.D. Ohio June 21, 2021) (“Noninfringement Decision ”); Lowe v. ShieldMark, Inc., No. 1:19-CV-748, ECF No. 87 (N.D. Ohio May 19, 2021) (“Claim Construction Order ”), J.A. 1–18; Lowe v. ShieldMark, Inc., No. 1:19-CV- 748, ECF No. 104 (N.D. Ohio July 16, 2021) (“Dismissal”), J.A. 27–31.

Because the district court erred in its claim construction , we vacate its decision granting summary judgment of noninfringement and remand for further proceedings consistent with this opinion. We affirm the court’s dismissal of Lowe’s declaratory judgment claim and denial of attorney fees.

BACKGROUND

Lowe and ShieldMark both sell floor marking tape, a product used to mark boundaries on a floor. Each party owns a patent that covers its tape product. Lowe owns the ’664 patent and sells its tape under the name “Superior Mark.” J.A. 99. ShieldMark owns the ’220 patent and sells its tape under the name “Mighty Line.” J.A. 383, 411. We begin with a brief overview of both patents.

LOWE v. SHIELDMARK, INC. 3

I

Lowe’s ’664 patent is directed to an improved floor marking tape. The specification explains that existing tape was “prone to being caught on floor cleaning devices or skids.” ’664 patent, col. 1 ll. 28–30. The patented invention purports to solve that problem by disclosing tape with features that prevent it from “unintentional lifting and delamination ” from the floor. Id. Abstract. The “[t]ape 10 generally includes a body 20 having an upper surface 22 and a lower surface 24.” Id. col. 2 ll. 19–24. The body has a “pair of lateral edges” that are “smoothly beveled,” thus “prevent[ing] tape 10 from being unintentionally lifted.” Id. col. 1 ll. 42–43; col. 2 ll. 23–27.

The specification further explains that “[i]n one embodiment ,” the tape has shoulders “that define[] a recess” to “hold[] the bulk of the adhesive.” Id. col. 1 ll. 56–59; see id. Abstract. The shoulders “prevent[] the adhesive from flowing out to the outer edge of the tape.” Id. col. 1 ll. 57–59. Figure 1, below, shows the tape (10) with shoulders (32), a recess (30), and a lower surface (24). Id. col. 2 ll. 28–33.

Claims 1 and 11 are the only independent claims.

Claim 1 reads as follows:

1. A floor marking tape adhered to a floor wherein the floor marking tape establishes a boundary on the floor; the combination comprising:

4 LOWE v. SHIELDMARK, INC.

a floor having an uppermost surface; the uppermost surface of the floor configured to support personnel and equipment thereupon; a floor marking tape having a body that has an upper surface and a lower surface; the lower surface facing the uppermost surface of the floor to which the floor marking tape is adhered such that the body of the floor marking tape is disposed above the uppermost surface of the floor; the body of the floor marking tape having a longitudinal direction; the body of the floor marking tape having first and second lateral edge portions disposed in the longitudinal direction; each of the first and second lateral edge portions having an upper surface and a lower surface; each of the first and second lateral edge portions having a width defined in a direction perpendicular to the longitudinal direction; the upper surface of each lateral edge portion comprising an extension of the upper surface of the body; the lower surface of each lateral edge portion being a flat coplanar extension of the lower surface of the body; the entire body of each lateral edge portion being tapered with the upper surface of the first lateral edge portion extending to the lower surface of the first lateral edge portion and the upper surface of the second lateral edge portion extending to the lower surface of the second lateral edge portion ;

LOWE v. SHIELDMARK, INC. 5

each of the first and second lateral edge portions having a maximum height that is less than its width; and an adhesive securing the lower surface of the body to the uppermost surface of the floor to establish a boundary.

Id. col. 5 ll. 2–36 (emphases added).

Claim 11 similarly recites a “a floor marking tape adhered to a floor” with a “body” and tapered “lateral edge portions.” Id. col. 6 ll. 1–36 (emphasis added).

Claims 10 and 20 depend from claims 1 and 11, respectively . They each recite that the tape has “a central body portion disposed between the first and second lateral edge portions.” Id. col. 5 ll. 61–67 (emphasis added); col. 6 ll. 61– 67 (emphasis added).

All of the remaining asserted claims depend from one of the above noted independent claims.

This appeal concerns one aspect of the claims: whether they require the tape to have “shoulders” and a “recess” such that it does not lie flat.

II

ShieldMark’s ’220 patent is directed to “a polymeric adhesive tape” with features that purport to prevent “wearing , tearing, cracking and breakage from heavy and repeated traffic.” ’220 patent, col. 1 ll. 21–39.

The tape “usually comprises a layer of polymeric material and at least one layer of adhesive material.” Id. col. 1 ll. 58–60. It “may optionally have an additional layer, such as a laminating substrate on an outermost side of the above adhesive layer.” Id. col. 1 ll. 63–65. The tape’s composition allegedly provides “superior ductility, strength, tear resistance [,] and abrasion resistance.” Id. col. 1 ll. 35–38.

6 LOWE v. SHIELDMARK, INC.

Claim 1 of the ’220 patent is representative and reads as follows:

1. A roll of an adhesive tape aisle marking system comprising: a layer of polyvinyl chloride having a Shore A Hardness between 92 and 100 and a thickness between 20 mil and 65 mil; a layer of adhesive physically contacting the layer of polyvinyl chloride, where the layer of adhesive has a thickness less than the thickness of the polymer layer; and a laminating substrate contacting the layer of adhesive , where the adhesive tape aisle marking system comprises a peel adhesion greater than 2.0 pounds per inch width when the laminating substrate is removed and a sample of the adhesive tape aisle marking system is adhered, the peel adhesion measured under a test method including peeling the sample of the adhesive tape aisle marking system at a 90 degree angle after application to a stainless steel panel.

Id. col. 4, ll. 34–52.

III

Free access — add to your briefcase to read the full text and ask questions with AI

Lowe v. Shieldmark, Inc., (Fed. Cir. 2022).

Lowe v. Shieldmark, Inc. (Lowe v. Shieldmark, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

MedImmune, Inc. v. Genentech, Inc.
549 U.S. 118 (Supreme Court, 2007)
Dow Jones & Co., Inc. v. Ablaise Ltd.
606 F.3d 1338 (Federal Circuit, 2010)
Lucent Technologies, Inc. v. Gateway, Inc.
580 F.3d 1301 (Federal Circuit, 2009)
Prasco, LLC v. Medicis Pharmaceutical Corp.
537 F.3d 1329 (Federal Circuit, 2008)
Jang v. Boston Scientific Corp.
532 F.3d 1330 (Federal Circuit, 2008)
Comark Communications, Inc. v. Harris Corporation
156 F.3d 1182 (Federal Circuit, 1998)
Etw Corporation v. Jireh Publishing, Inc.
332 F.3d 915 (Sixth Circuit, 2003)
Highmark Inc. v. Allcare Health Management System, Inc.
134 S. Ct. 1744 (Supreme Court, 2014)
Shire Development, LLC v. Watson Pharmaceuticals, Inc.
787 F.3d 1359 (Federal Circuit, 2015)
Kaneka Corp. v. Xiamen Kingdomway Group Co.
790 F.3d 1298 (Federal Circuit, 2015)
Sfa Systems, LLC v. Newegg Inc.
793 F.3d 1344 (Federal Circuit, 2015)
Openwave Systems, Inc. v. Apple Inc.
808 F.3d 509 (Federal Circuit, 2015)
Unwired Planet, LLC v. Apple Inc.
829 F.3d 1353 (Federal Circuit, 2016)
Wi-Lan USA, Inc. v. Apple Inc.
830 F.3d 1374 (Federal Circuit, 2016)
Asia Vital Components Co. v. Asetek Danmark A/S
837 F.3d 1249 (Federal Circuit, 2016)
Poly-America, L.P. v. Api Industries, Inc.
839 F.3d 1131 (Federal Circuit, 2016)
Bayer Cropscience Ag v. Dow Agrosciences LLC
851 F.3d 1302 (Federal Circuit, 2017)
Raniere v. Microsoft Corporation
887 F.3d 1298 (Federal Circuit, 2018)